29878-31-7 Usage
Description
4-Methyl-1H-benzotriazole is a benzotriazole derivative characterized as a brown solid. It is known for its effectiveness as a corrosion inhibitor and is also used as an additive in the formulation of aircraft deicing and anti-icing fluids (ADAFs).
Uses
Used in Corrosion Inhibition:
4-Methyl-1H-benzotriazole is used as a corrosion inhibitor for various applications, including industrial processes and the protection of metals from corrosion. Its chemical properties make it an effective agent in preventing the degradation of metal surfaces, thus prolonging their lifespan and maintaining their structural integrity.
Used in Aircraft Deicing and Anti-icing Fluids (ADAFs):
In the aviation industry, 4-methyl-1H-benzotriazole is used as an additive in formulated aircraft deicing and anti-icing fluids. Its inclusion in these fluids helps to prevent the formation of ice on aircraft surfaces, ensuring safe and efficient flight operations during cold weather conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 29878-31-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,8,7 and 8 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 29878-31:
(7*2)+(6*9)+(5*8)+(4*7)+(3*8)+(2*3)+(1*1)=167
167 % 10 = 7
So 29878-31-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H7N3/c1-5-3-2-4-6-7(5)9-10-8-6/h2-4H,1H3,(H,8,9,10)
29878-31-7Relevant articles and documents
COMPOUNDS AS INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR
-
Paragraph 0126, (2020/09/27)
The present invention provides compounds of Formula (I) shown above and their pharmaceutically acceptable salt, solvates, isomers, or prodrugs, as well as pharmaceutical compositions containing these compounds. Also provided by the invention is a method for treating a disorder mediated by macrophage migration inhibitory factor in a subject, comprising administering to the subject in need thereof a compound or a pharmaceutical composition of this invention.
Visible-light-mediated C2-amination of thiophenes by using DDQ as an organophotocatalyst
Song, Chunlan,Yi, Hong,Dou, Bowen,Li, Yiying,Singh, Atul K.,Lei, Aiwen
supporting information, p. 3689 - 3692 (2017/04/03)
In this work, a direct C-H activation of thiophenes was presented via an oxidation pathway under visible-light irradiation, in which the thiophene radical cation serves as the key intermediate. Various thiophenes and azoles could be transformed into the corresponding amination products well, and H2O was the only byproduct which is environmentally benign. Our results showed that tert-butyl nitrite (TBN) served as the electron transfer mediator and O2 as the terminal oxidant to regenerate the photocatalyst DDQ and revive the photocatalytic cycle.
Metabolism of 1H-benzotriazolecarboxylic acids in vitro and in vivo
Hoffmann,Jacobi
, p. 457 - 459 (2007/10/02)
-